SC 13G/A: Adagene Inc.

Ticker: ADAG · Form: SC 13G/A · Filed: 2024-11-07T00:00:00.000Z

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Adagene Inc..

Risk Assessment

Risk Level: low

From the Filing

0001193125-24-253175.txt : 20241107 0001193125-24-253175.hdr.sgml : 20241107 20241107163213 ACCESSION NUMBER: 0001193125-24-253175 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 GROUP MEMBERS: PANACEA INNOVATION LTD GROUP MEMBERS: PANACEA VENTURE HEALTHCARE FUND II GP COMPANY, LTD. GROUP MEMBERS: PANACEA VENTURE HEALTHCARE FUND II, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adagene Inc. CENTRAL INDEX KEY: 0001818838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92270 FILM NUMBER: 241436387 BUSINESS ADDRESS: STREET 1: 4F, BUILDING C14, NO. 218, XINGHU STREET STREET 2: SUZHOU INDUSTRIAL PARK CITY: JIANGSU STATE: F4 ZIP: 00000 BUSINESS PHONE: 86-512-87773632 MAIL ADDRESS: STREET 1: 4F, BUILDING C14, NO. 218, XINGHU STREET STREET 2: SUZHOU INDUSTRIAL PARK CITY: JIANGSU STATE: F4 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Huang James CENTRAL INDEX KEY: 0001573160 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE STREET 2: SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 SC 13G/A 1 d882300dsc13ga.htm SC 13G/A SC 13G/A Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Adagene Inc. (Name of Issuer) Ordinary Shares (Title of Class of Securities) 005329 107** (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. ** There is no CUSIP number assigned to the ordinary shares. CUSIP number 005329 107 has been assigned to the American depositary shares (ADSs) of the Issuer, which are quoted on NASDAQ Stock Market under the symbol ADAG. Each ADS represents one and one quarter ordinary shares, par value US$0.0001 per share. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. G1933S101 Schedule 13G Page 1 of 9  1   Names of Reporting Persons   Panacea Venture Healthcare Fund I I, L.P.  2  Check the Appropriate Box if a Member of a Group  (a) ☐  (b) ☐  3  SEC Use Only  4  Citizenship or Place of Organization   Cayman Islands Number of Shares Beneficially  Owned by Each Reporting Person With 5   Sole Voting Power   0 6  Shared Voting Power   4,015,000 7  Sole Dispositive Power   0 8  Shared Dispositive Power   4,015,000  9   Aggregate Amount Beneficially Owned by Each Reporting Person   4,015,000 10  Check if the Aggregate Amount in Row (9) Excludes Certain Shares   Not Applicable 11  Percent of Class Represented by Amount in Row 9   7.3% 12  Type of Reporting Person   PN CUSIP No. 005329 107 Schedule 13G Page 2 of 9  1   Names